Thomas C. Beadnell
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- Mitochondrial Function and Pathology
Papers in
-
- Mitochondrial Function and Pathology 5
- PI3K/AKT/mTOR signaling in cancer 3
- RNA modifications and cancer 3
- Oncology 10
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- Co-authors
- Danny R. Welch (7 shared papers)Kathryn L. Schwertfeger (4 shared papers)Adam D. Scheid (4 shared papers)Wuming Gong (1 shared paper)Yuen‐Yi Tseng (1 shared paper)Peter Ronning (1 shared paper)Yasuhiko Kawakami (1 shared paper)M. Gerard O’Sullivan (1 shared paper)
- Journals
- Cancer Research (3 papers)British Journal of Cancer (2 papers)Clinical & Experimental Metastasis (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Thomas C. Beadnell
18 papers receiving 1.1k citations
Thomas C. Beadnell's Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 568
- Molecular Biology 737
- Oncology 169
- Immunology 84
- Pathology and Forensic Medicine 45
Countries citing papers authored by Thomas C. Beadnell
This map shows the geographic impact of Thomas C. Beadnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Beadnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Beadnell more than expected).
Fields of papers citing papers by Thomas C. Beadnell
This network shows the impact of papers produced by Thomas C. Beadnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Beadnell. The network helps show where Thomas C. Beadnell may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas C. Beadnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PVT1 dependence in cancer with MYC copy-number increase Hit paper breakdown → | 2014 | 574 |
| 2 | 2020 | 87 | |
| 3 | 2013 | 63 | |
| 4 | 2012 | 63 | |
| 5 | 2018 | 46 | |
| 6 | 2021 | 45 | |
| 7 | 2010 | 38 | |
| 8 | 2018 | 35 | |
| 9 | 2019 | 19 | |
| 10 | 2016 | 19 | |
| 11 | 2019 | 15 | |
| 12 | 2020 | 13 | |
| 13 | 2014 | 13 | |
| 14 | 2017 | 11 | |
| 15 | 2019 | 9 | |
| 16 | 2023 | 6 | |
| 17 | 2024 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2025 | 0 |
About Thomas C. Beadnell
Thomas C. Beadnell is a scholar working on Molecular Biology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Immunology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Mitochondrial Function and Pathology (5 papers), Cancer-related Molecular Pathways (4 papers), Cancer Cells and Metastasis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), RNA modifications and cancer (3 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (568 citations), Molecular Biology (737 citations), Oncology (169 citations), Immunology (84 citations) and Pathology and Forensic Medicine (45 citations). Thomas C. Beadnell has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Danny R. Welch, Kathryn L. Schwertfeger, Adam D. Scheid, Wuming Gong, Yuen‐Yi Tseng, Peter Ronning, Yasuhiko Kawakami, M. Gerard O’Sullivan, Hiroko Kawakami and York Marahrens. Their work appears in journals such as Cancer Research, British Journal of Cancer, Clinical & Experimental Metastasis, Molecular Cancer Therapeutics and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.